Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan W Partin

Showing results (281-290 of 349) with videos related to

Pageof 35
Sort By:
BJU International|June 14, 2013
Trends in immediate perioperative morbidity and delay in discharge after open and minimally invasive radical prostatectomy (RP): a 20-year institutional experiencePhillip M Pierorazio, Jeffrey K Mullins, Ashley E Ross, et al.
Urology|February 25, 2003
Proenzyme psa for the early detection of prostate cancer in the 2.5-4.0 ng/ml total psa range: preliminary analysisLori J Sokoll, Daniel W Chan, Stephen D Mikolajczyk, et al.
BJU International|January 7, 2017
Prostate Health Index density improves detection of clinically significant prostate cancerJeffrey J Tosoian, Sasha C Druskin, Darian Andreas, et al.
Clinical Genitourinary Cancer|September 19, 2019
PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical ProstatectomyMark C Markowski, Yongmei Chen, Zhaoyong Feng, et al.
The Prostate|September 16, 2004
Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarraysDennis A Faith, William B Isaacs, James D Morgan, et al.
BJU International|November 15, 2011
Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsiesBruce J Trock, Michelle J Brotzman, Leslie A Mangold, et al.
The Journal of Urology|June 16, 2009
Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomyLionel L Bañez, Leon Sun, Bruce J Trock, et al.
BJU International|April 16, 2014
Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk featureFarzana A Faisal, Debasish Sundi, Phillip M Pierorazio, et al.
European Urology|April 30, 2015
Utility of Risk Models in Decision Making After Radical Prostatectomy: Lessons from a Natural History Cohort of Intermediate- and High-Risk MenAshley E Ross, Kasra Yousefi, Elai Davicioni, et al.
Cancer|August 11, 2006
Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10Patrick J Bastian, Mark L Gonzalgo, William J Aronson, et al.
Pageof 35

Showing results (281-290 of 349) with videos related to

Sort By:
Pageof 35
BJU International|June 14, 2013
Trends in immediate perioperative morbidity and delay in discharge after open and minimally invasive radical prostatectomy (RP): a 20-year institutional experiencePhillip M Pierorazio, Jeffrey K Mullins, Ashley E Ross, et al.
Urology|February 25, 2003
Proenzyme psa for the early detection of prostate cancer in the 2.5-4.0 ng/ml total psa range: preliminary analysisLori J Sokoll, Daniel W Chan, Stephen D Mikolajczyk, et al.
BJU International|January 7, 2017
Prostate Health Index density improves detection of clinically significant prostate cancerJeffrey J Tosoian, Sasha C Druskin, Darian Andreas, et al.
Clinical Genitourinary Cancer|September 19, 2019
PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer After Radical ProstatectomyMark C Markowski, Yongmei Chen, Zhaoyong Feng, et al.
The Prostate|September 16, 2004
Trefoil factor 3 overexpression in prostatic carcinoma: prognostic importance using tissue microarraysDennis A Faith, William B Isaacs, James D Morgan, et al.
BJU International|November 15, 2011
Evaluation of GSTP1 and APC methylation as indicators for repeat biopsy in a high-risk cohort of men with negative initial prostate biopsiesBruce J Trock, Michelle J Brotzman, Leslie A Mangold, et al.
The Journal of Urology|June 16, 2009
Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomyLionel L Bañez, Leon Sun, Bruce J Trock, et al.
BJU International|April 16, 2014
Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk featureFarzana A Faisal, Debasish Sundi, Phillip M Pierorazio, et al.
European Urology|April 30, 2015
Utility of Risk Models in Decision Making After Radical Prostatectomy: Lessons from a Natural History Cohort of Intermediate- and High-Risk MenAshley E Ross, Kasra Yousefi, Elai Davicioni, et al.
Cancer|August 11, 2006
Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10Patrick J Bastian, Mark L Gonzalgo, William J Aronson, et al.
Pageof 35